A portrait of the Department's research! Our web site has some abstracts; others are usually available from the Medline Database. Publications are available for 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006 2007, 2008, 2009 & 2010 .



Blyth, B.J., Azzam, E.I., Howell, R.W., Ormsby, R.J., Staudacher, A.H. and Sykes, P.J.  An adoptive transfer method to detect low dose radiation-induced bystander effects in vivo. Radiation Research 173: 125-137, 2010.

Martin-Harris, M.H., Bartley, P.A. and Morley, A.A. Gene walking using sequential hybrid primer polymerase chain reaction. Analytical Biochemistry 399: 308-310, 2010.

back to top



Brisco, M.J., Latham, S., Sutton, R., Hughes, E., Wilczek, V., van Zanten, K., Budgen, B., Bahar, A.Y., Malec, M., Sykes, P.J., Kuss, B.J., Waters, K., Venn, N.C., Giles, J.E., Haber, M., Norris, M.D., Marshall, G.M. and Morley, A.A. Determining the repertoire of IGH gene rearrangements in order to develop molecular markers for mininimal residual disease in acute lymphoblastic leukemia.  Journal of Molecular Diagnostics 11: 194-200, 2009.

Hooker, A.M., Grdina, D.J., Murley, J.S., Blyth, B.J., Ormsby, R.J., Bezak, E., Giam, K.A. and Sykes, P.J. Low doses of amifostine protect from chromosomal inversions in spleen in vivo when administered after an occupationally relevant X-radiation dose. Int. J. Low Radiation 6: 43-56, 2009.

Lassen, M.R., Raskob, G.E., Gallus, A., Pineo, G., Chen, D. and Portman, R.J. Apixaban or enoxaparin for thromboprophylaxis after knee replacement.  New Engl. J Med. 361: 594-604, 2009.

Morley, A.A., Latham, S., Brisco, M.J., Sykes, P.J., Sutton, R., Hughes, E., Wilczek, V., Budgen, B., van Zanten,K., Kuss, B.J., Venn, N.C., Norris, M.D., Crock, C., Story, C.  and Waters, K. Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemia. Journal of Molecular Diagnostics 11: 201-210, 2009.

back to top



Friedman, R.J., Gallus, A.S., Cushner, F.D., FitzGerals, G., Anderson, F.A. (for the GLORY Investigators). Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Current Medical Research and Opinions 24: 87-97, 2008.

Grist, S.A., Dubowsky, A. and Suthers, G. Evaluating DNA sequence variants of unknown biological significance.  In:  Clinical Bioinformatics  Series: Methods in Molecular Medicine 141: 199-217, 2008.

Shortt, J., Westall, G.P., Roxby, D., Chen, J.W., Snell, G.I., Polizzotto, M.N., Magrin, G., Webb, A., Street, A.M., Borosak, M., Wood, E.M. and Cole-Sinclair, M.F. A ‘dangerous’ group O donor: severe hemolysis in all recipients of organs from a donor with multiple red cell alloantibodies.  American J Transplantation 8: 711-714, 2008.

Gallus, A. Which patients with venous thromboembolism are at risk for fatal pulmonary embolism? Nature Clinical Practice 5: 604-605, 2008.

Zoossmann-Diskin, A., Swinburne, S., Shohat, M., Peleg, L., Gazit, E. and Turner, D. Typical classical polymorphisms by real-time PCR: analysis of the GPT and ALAD protein polymorphisms in the Jewish populations. American J Human Biology 20: 490-492, 2008.

back to top



Agnelli, G., Gallus, A., Goldhaber, S.Z., Haas, S., Huisman, M.V., Hull, R.D., Kakkar, A.K., Misselwitz, F., Schellong, S. for the ODIXa-DVT Study Investigators. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor Rivaroxaban (BAY 59-7939). The ODIXa-DVT (Oral Driect Factor Xa Inhibitor BAY 59-7939 in patinets with acute symptomatic deep-vein thrombosis) study. Circulation 116: 180-187, 2007.

Bai, H., Wilson, T.M., Grist, S., Gardner, J., Suthers, G. and Lu A-L. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis. Cancer Letters 250: 74-81, 2007.

Buller, H.R., Cohen, A.T., Davidson, B., Decousus, H., Gallus, A.S., Gent, M., Pillion, G., Piovella, F. Prins, M.H., Raskob, G.E. (The van Gogh Investigators). Idraparinux versus standard therapy for venous thromboembolic disease. New England Journal of Medicine 357: 1094-1104, 2007.

Buller, H.R., Cohen, A.T., Davidson, B., Decousus, H., Gallus, A.S., Gent, M., Pillion, G., Piovella, F. Prins, M.H., Raskob, G.E. (The van Gogh Investigators). Extended prophylaxis of venous thromboembolism with Idraparinux. New England Journal of Medicine 357: 1105-1112, 2007.

Carvalho, M.A., Marsillac, S.M., Karchin, R., Manoukian, S., Grist, S., Swaby, R.F., Urmenyi, T.P., Rondinelli, E., Silva, R., Gayol, L., Baumbach, L., Sutphen, R., Pickard, J.L., Nathanson, K.L., Sali, A., Goldgar, D., Couch, F.J., Radice, P. and Monteiro, A.N.A. Determination of cancer risk associated with germline BRCA1 missense variants by functional analysis. Cancer Research 67: 1494-1501, 2007.

Day, T.K., Hooker, A.M., Zeng G. and Sykes, P.J.Low dose X-radiation adaptive response in spleen and prostate of Atm heterozygous mice,  International J Radiation Biology 83: 523-534, 2007.

Day, T.K., Zeng, G., Hooker, A.M., Bhat, M., Scott, B., Turner, D.R. and Sykes, P.J. Adaptive response for chromosomal inversions in pKZ1 mouse prostate induced by low doses of X-radiation delivered after high dose. Radiation Research 167: 682-692, 2007.

Day, T.K., Zeng, G., Hooker, A.M., Bhat, M., Turner, D.R. and Sykes, P.J. Extremely low doses of X-radiation can induce adaptive responses in mouse prostate. Dose-Response 5: 315-322, 2007.

Lassen, M.R., Davidson, B.L., Gallus, A., Pineo, G., Ansell, J. and Deitchman, D. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement. J of Thrombosis and Haemostasis 5: 2368-2375, 2007.

McEwen, M.P., Roxby, D. Can latent heat safely warm blood? In vitro testing of a portable prototype blood warmer. BMC Emergency Medicine 7: 8, 2007.

Sykes, P.J. and Day, T.K. Requirements for identification of low dose and non-linear mutagenic responses to ionising radiation. Dose-Response 5: 308-314, 2007.

Tomkowski, W.Z., Davidson, B.L., Wisniewska, J., Malek, G., Kober, J., Kuca, P., Burakowska, B., Oniszh, Gallus, A.S., Lensing, A.W.A. Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patients. Thrombosis and Haemostasis 97: 191-194, 2007.

Zoossmann-Diskin, A. Relation of male circumcision to cervical cancer, sexuality and female circumcision. Journal of Men’s Health & Gender 4: 448-453, 2007.

back to top



Chen, C.S., Phillips, K.D., Grist, S., Bennet, G., Craig, J.E., Muecke, J.S. and Suthers, G.K. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. Familial Cancer 5: 397-404, 2006.

Dare, R., Sykes, P.J., Morley, A.A. and Brisco, M.J. Effect of age on the repertoire of cytotoxic memory (CD8+CD45RO+) T cells in peripheral blood: the use of rearranged T cell receptor g genes as clonal markers. J Immunol Methods 308: 1-12, 2006.

Day, T.K., Zeng, G., Hooker, A.M., Bhat, M., Scott, B.R., Turner, D.R. and Sykes, P.J. Extremely low priming doses of X radiation induce an adaptive response to chromosomal inversions in pKZ1 mouse prostate. Radiation Research 166: 757-766, 2006.

Koczwara, B., Barton, M.B., Tattersall, M.H., Turner, D.R., Olver, I.N. and Starmer, D.L. How not to effect change in curricula. Medical Journal of Australia 185: 52, 2006.

Sykes, P.J., Morley, A.A. and Hooker, A.M. The pKZ1 recombination mutation assay: a sensitive assay for low dose studies. Dose Response 4: 91-105, 2006.

Sykes, P.J., Day, T.K., Swinburne, S.J., Lane, J.M., Bhat, M. Morley, A.A.  and Hooker, A.M. In vivo mutagenic effect of VERY low dose radiation. Dose Response 4: 309-316, 2006.

Waddell, N., Jonnalagadda, J., Marsh, A., Grist, S., Jenkins, M., Taylor, D., Hobson, K., Taylor, M., Lindeman, G., Tavtigian, S., Suthers, G., Goldgar, D., Oefner, P., kConFab Investigators, Taylor, D., Grimmond, S., Khanna, K. and Chenevix-Trench, G. Characterization of the breast-cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling. Genes, Chromosomes and Cancer 45: 1169-1181, 2006.

Zeng, G., Hooker, A.M., Day, T.K., Blyth, B.J., Bhat, M. and Sykes P.J. Non-linear chromosomal inversion response in prostate after low dose radiation exposure. Mutation Research 602: 65-73, 2006.

Zoossmann-Diskin, A. Ashkenazi levites’ “Y modal haplotype” (LMH) – an artificially created phenomenon? J. Comparative Human Biology 57: 87-100, 2006.

back to top



Agnelli, G., Bergqvist, D., Cohen, A.T., Gallus, A.S. and Gent, M. Randomized clinical trial of postoperative foundaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Brit J Surgery 92: 1212-1220, 2005.

Gallus, A.S. Travel, venous thromboembolism, and thrombophilia. Seminars in Thrombosis and Haemostasis 31: 90-96, 2005.

Gallus, A.S. Management options for thrombophilias. Seminars in Thrombosis and Haemostasis 31: 118-126, 2005.

Jessup, C.F., Brereton, H.M., Sykes, P.J., Thiel, M.A., Coster, D.J. and Williams, K.A. Local gene transfer to prevent rat corneal allograft rejection. Invest. Ophthalmool. Vis. Sci. 46: 1675-1681, 2005.

Klebe, S., Coster, D.J., Sykes, P.J., Swinburne, S., Hallsworth, P., Scheerlinck, J-P.Y., Krisnan, R. and Williams K.A. Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J. Immunology 175: 2219-2226, 2005.

Koczwara, B., Tattersall, M.H.N., Barton, M.B., Coventry, B.J., Dewar, J.M., Millar, J.L., Olver, I.N., Schwarz, M.A., Starmer, D.L., Turner, D.R. and Stockler, M.R. Achieving equal standards in medical student education: is a national exit examination the answer? Medical Journal of Australia 182: 228-230, 2005.

Piovella, F., Wang, C-J., Lu, H., Lee, K., Lee, L.H., Lee, W.C., Turpie, A.G.G., Gallus, A.S., Planes, A., Passera R. and Rouillon, A. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. Journal of Thrombosis and Haemostasis 3: 2664-2670, 2005.

back to top



Grist, S.A., Lu, X-J. and Morley, A.A. Mitochondrial mutations in acute leukemia. Leukemia 18: 1313-1316, 2004.

Hooker, A.M., Morley, A.A., Tilley, W.D. and Sykes, P.J. Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesis. Mutation Res. 550: 1-10, 2004.

Hooker, A.M., Bhat, M., Day, T.K., Lane, J.M., Swinburne, S.J., Morley, A.A. and Sykes, P.J. The linear no-threshold model does not hold for low-dose ionizing radiation. Radiation Res. 162: 447-452, 2004.

Lindeman, G.J., Hiew, M., Visvader, J.E., Leary, J., Field, M., Gaff, C.L., Gardner, R.J.M., Trainor, K., Cheetham, G., Suthers, G. and Kirk J. Frequency of the ATM IVS10-6TÆG variant in Australian multiple-case breast cancer families. Breast Cancer Res., 6: R401-R407, 2004.

Roberts-Thomson, P.J., Male, D.A., Walker, J.G., Cox, S.R., Shen, X., Smith, M.D., Ahern, M.J. and Turner, D.R. Genomic instability in scleroderma. Asian Pacific J Allergy and Immunology 22: 153-158, 2004.

Van Den Bos, M., Marotta, R., Goldup, S., Chataway, T., Firgaira, F. and Thyagarajan, D. Writer’s cramp in an Australian pedigree with DYT1 dystonia. J. Clin. Neurosci. 11: 537-539, 2004.

Zoossmann-Diskin, A., Gazit, E., Peleg, L., Shohat, M. and Turner, D.R. 844ins68 in the cystathione b-synthase gene in Israel and review of its distribution in the world. Anthrop. Anz. 62: 147-155, 2004.

back to top



Campbell, P.J. and Morley, A.A. Modelling a minimal residual disease-based treatment strategy in acute lymphoblastic leukaemia. British Journal of Haematology 122: 30-38, 2003.

Chalmers, A.H. Comments on the proposed National Guidelines for analysis of cerebropsinal fluid for bilirubin in suspected subarachnoid haemorrhage. Clinical Biochem. Rev. 24: 131-133, 2003.

Chalmers, A.H., Blake-Mortimer, J.S. and Winefield, A.H. The prooxidant state and psychologic stress. Environ. Health Perspect. 111: A16-A17, 2003.

Gallus, A.S. and Coghlan, D.W. Travel and venous thrombosis. Phlebotomy Digest 16: 23-26, 2003.

Hapuarachchi, J.R., Chalmers, A.H., Winefield, A.H. and Blake-Mortimer, J.S. Changes in clinically relevant metabolites with psychological stress parameters. Behavioural Med. 29: 52-59, 2003.

Marshall, G.M., Haber, M., Kwan, E., Zhu, L., Ferrara, D., Chengyuan, X., Brisco, M.J., Sykes, P.J., Morley, A., Webster, B., Dalla Pozza, L., Waters, K. and Norris, M.D. Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. Journal of Clinical Oncology 21: 704-709, 2003.

McEvoy, C.R.E., Morley, A.A. and Firgaira, F.A. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia. Genes, Chromosomes and Cancer 37: 321-325, 2003.

Squitieri, F., Gellera, C., Cannella, M., Mariotti, C., Cislaghi, G., Rubinsztein, D.C., Almqvist, E.W., Turner, D., Bachoud-Levi, A-C., Simpson, S.A., Delatycki, M., Maglione, V., Hayden, M.R. and Donato, S.D. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126: 946-955, 2003.

Turner, D.R., Dreimanis, M., Holt, D., Firgaira, F.A. and Morley, A.A. Mitotic recombination is an important mutational event following oxidative damage. Mutation Research 522: 21-26, 2003.

Turner, D.R. ……… And Man Made Dolly. R. Williams (ed: R Williams), “Asimov’s Elephant”, pp 44-50, ABC Books, Sydney (ISBN 0 7333 1150 4), 2003.

Zhu, G., Duffy, D.L., Turner, D.R., Ewen, K.R., Montgomery, G.W. and Martin, N.G. Linkage and association analysis of radiation damage repair genes XRCC3 and XRCC5 with nevus density in adolescent twins. Twin Research 6: 315-321, 2003.

back to top



Kuss, B.J., Corbo, M., Lau, W-M., Fennell, D.A., Dean, N.M. and Cotter, F.E. In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapy. International Journal of Cancer 98: 128-133, 2002.

Hooker, A.M., Horne, R., Morley, A.A. and Sykes, P.J. Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposide. Mutation Research 500: 117-124, 2002.

Male, D.A., Phillips, P. and Turner, D.R. Improved polymerase chain reaction-based glycophorin-A M/N blood group allelotyping. Vox Sanguinis 83: 170-171, 2002 (letter).

McEvoy, C.R.E., Seshadri, R., Morley, A.A. and Firgaira, F.A. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer. Tissue Antigens 60: 235-43, 2002.

back to top



Brisco, M.J. Quantifying residual leukemia by clone-specific polymerase chain reaction. In: Hematologic Malignancies: Methods and Techniques, BG Faguet (ed), Methods in Molecular Medicine, No. 55, Humana Press Inc, pp 133-156 (2001) (ISBN 0-89603-543-3).

Brisco, M.J., Sykes, P.J., Hughes, E., Neoh, S-H., Snell, L.E., Dolman, G., Peng, L-M., Toogood, I.R.G., Cheney, K., Rice, M.S., Story, C.J. and Morley, A.A. Comparison of methods for assessment of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia. Leukemia 15: 385-390, 2001.

Brisco, M.J, Sykes, P.J., Hughes, E., Story, C.J., Rice, M.S., Schwarer, A.P. and Morley, A.A. Molecular relapse can be detected in blood in a sensitive and timely fashion in B lineage acute lymphoblastic leukemia. Leukemia 15: 1801-1802, 2001.

Burrows, R.F., Gan, E.T., Gallus, A.S., Wallace, E.M. and Burrows, E.A. A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study. British Journal of Obstetrics and Gynaecology, 108: 1-5, 2001.

Campbell, P., Roberts, G., Eaton, V., Coghlan, D. and Gallus, A.S. Managing warfarin therapy in the community. Aust. Presciber 24: 86-89, 2001.

Chalmers, A.H. Cerebrospinal fluid xanthochromia testing simplified. Clinical Chemistry 47: 147-148, 2001.

Chong, B.H., Gallus, A.S., Cade, J.F., Magnani, H., Manoharan, A., Oldmeadow, M., Arthur, C., Rickard, K., Gallo, J., Lloyd, J., Seshadri, P., and Chesterman, C.N. (The Australian Hit Study Group) Prospective randomised open-label comparison of danaparoid and dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis. A clinical outcome study. Thrombosis & Haemostasis 86: 1170-1175, 2001.

Cleton-Jansen, A.M., Callen, D.F., Seshadri, R., Goldup, S., McCallum, B., Crawford, J., Powell, J.A., Settasatian, C., van Beerendonk, H., Moerland, E.W., Smit, V.T.B.H.M., Harris, W.H., Millis, R., Morgan, N.V., Barnes, D., Mathew, C.G. and Cornelisse, C.J. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Research 61: 1171-1177, 2001.

Gallus, A.S. and Baker, R.I. Economy class syndrome. Medical J Australia 174: 264-265, 2001.

Giannakis, E., Male, D.A., Ormsby, R.J., Mold, C., Jokiranta, T.S., Ranganathan, S. and Gordon, D.L. Multiple ligand binding sites on domain seven of human complement factor H. International Immunopharmacology 1: 433-443, 2001.

Hague, W.M., North, R.A., Gallus, A.S., Walters, B.N.J., Orlikowski, C., Burrows, R.F., Cincotta, R.B., Dekker, G.A., Higgins, J.R., Lowe, S.A., Morris, J.M., Peek, M.J. (A Working Group on behalf of the Obstetric Medicine Group of Australasia). Anticoagulation in pregnancy and the puerperium. Medical J Australia 175: 258-263, 2001.

Henry, J.M., Morley, A.A. and Sykes, P.J. Purging of myeloma cells using All-trans retinoic acid in a mouse model. Experimental Hematology 29: 315-321, 2001.

Klebe, S, Sykes, P.J., Coster, D.J., Bloom, D.C. and Williams, K.A. Gene transfer to ovine corneal endothelium. Experimental Ophthalmology 29: 316-322, 2001.

Klebe, S., Sykes, P.J., Coster, D.J., Krishnan, R. and Williams, K.A. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 71: 1214-1220, 2001.

Levanon, D., Glusman, G., Bangsow, T., Ben-Asher, E., Male, D.A., Avidan, N., Bangsow, C., Hattori, M., Taylor, T.D., Taudien, S., Blechschmidt, K., Shimizu, N., Rosenthal, A., Sakaki, Y., Lancet, D. and Groner, Y. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1AML1. Gene 262: 23-33, 2001.

Morley, A.A. and Trainor, K.J. Lack of an effect of vitamin E on lifespan of mice. Biogerontology 2: 109-112, 2001.

Powell, B.L., Bydder, S., Grieu, F., Gnanasampanthan, G., Elsaleh, H., Seshadri, R., Berns, E.M.J.J. and Iacopetta, B. Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients. Breast Cancer Research and Treatment 69: 65-68, 2001.

Seshadri, P. and Seshadri, R. Hairy cell leukemia: treatment prospects. Expert Rev Anticancer Ther 1: 91-98, 2001.

Sykes, P.J. Detection of monoclonal immunoglobulin and T cell receptor rearrangements in B and T cell malignancies by polymerase chain reaction. In: Hematologic Malignancies: Methods and Techniques, BG Faguet (ed), Methods in Molecular Medicine, No. 55, Humana Press Inc, pp 117-132 (2001) (ISBN 0-89603-543-3).

Sykes, P.J., McCallum, B.D., Bangay, M.J., Hooker, A.M. and Morley, A.A. Effect of 900 MHz radiofrequency radiation exposure on intrachromosomal recombination in pKZ1 mice. Radiation Research 156: 495-502, 2001.

Turpie, A.G.G., Joek, J.A. and Gallus, A.S. Synthetic pentasaccharide in the prevention of deep vein thrombosis after total hip replacement. New Engl. J Medicine 344: 619-625, 2001.

back to top



Brisco, M., Sykes, P., Dolman, G., Hughes, E., Neoh, S., Peng, L., Snell, L., Toogood, I., Rice, M. and Morley, A. Early resistance to therapy during induction in childhood acute lymphoblastic leukemia. Cancer Research 60: 5092-5096, 2000.

Gallus, A.S., Baker, R.I. Chong, B.H., Ockelford, P.A. and Street, A.M. Consensus guidelines for warfarin therapy. Med. J. Australia 172: 600-605, 2000.

Pauletti, G., Dandekar, S., Rong, H.M., Ramos, L., Peng, H.M., Seshadri, R., and Slamon, D. Assessment of methods for tissue based detection of the Her-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry. J. Clinical Oncology 18: 3651-3664, 2000.

Powell, B., Soong, R., Iacopetta, B., Seshadri, R. and Smith, D. R. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clinical Cancer Research 6(2): 443-51, 2000.

The Rembrandt Investigators (B?ller, H.R., Cariou, R., Gallus, A.S., Gent, M., Ginsberg, J. and Prins, M.H.) Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A Phase III Evaluation. Circulation 102(22): 2726-2731, 2000.

Toouli, C.D., Turner, D.R., Grist, S.J. and Morley, A.A. The effect of cycle number and target size on PCR amplification of polymorphic repetitive sequences. Analytical Biochemistry 280: 324-326, 2000.

back to top



Chalmers, A.H. Smoking and oxidative stress. Am. J. Clin. Nutrition 69: 572, 1999. (letter)

Chalmers, A.H. . 5?-Ectonucleotidase in chronic lymphocytic leukemia. Clin. Biochem. 32: 91, 1999. (letter)

Crawford, J., Ianzano, I., Savino, M., Whitmore, S., Cleton-Jansen, A.M., Settasatian, C., d?Apolito, M., Seshadri, R., Pronk, J.C., Auerbach, A.D., Verlander, P., Mathew, C.G., Tipping, A.J., Doggett, N.A., Zelante, L., Callen, D.F. and Savoia, A. The PISSLRE gene: Structure, exon skipping, and exclusion as tumor suppressor in breast cancer. Genomics 56: 90-97, 1999.

Firgaira, F.A., Seshadri, R., McEvoy, C.R.E., Dite, G., Giles, G.G., McCredie, M.R.E., Southey, M.C., Venter, D.J. and Hopper, J.L.: HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. J. Natl. Cancer Inst. 91: 2107-2111, 1999.

Gallus, A.S. Towards the safer use of warfarin I: An overview. J. Qual. Clin. Practice 19: 55-59, 1999.

Gallus, A.S. Applying risk assessment models in orthopaedic surgery: overview of our clinical experience. Blood Coagulation and Fibrinolysis 10: (Suppl. 2) S53-S61, 1999.

Halstead, P.J, Roughead, E.E., Rigby, K., Clark, R.B. and Gallus, A.S. Towards the safer use of warfarin II: Results of a workshop. J. Qual. Clin. Practice 19: 61-62, 1999.

Holt, D., Dreimanis, M., Pfeiffer, M., Firgaira, F., Morley, A. and Turner, D. Inter-individual variation in mitotic recombination. American J Human Genetics 65: 1423-1427, 1999.

Kuss, B.J. and Cotter, F. ANTISENSE ? Time to kill messenger. Annals of Oncology 10: 495-503, 1999.

Lockwood, C., Ricciardelli, C., Raymond, W.A., Seshadri, R., McCaul, K. and Horsfall, D.J. A simple index using video image analysis to predict outcome in primary breast cancer. Int. J. Cancer 84: 203-208, 1999.

Kirschstein, S., Winter, S., Turner, D. and Lober, G. Detection of the DeltaF508 mutation in the CFTR genes by means of time-resolved fluorescence methods. Bioelectrochemistry & Bioenergetics 48: 415-421, 1999.

Morley, A.A. Periodic hematological disorders. Blood 93: 4023-4024, 1999 (letter).

Morley, A.A. and Turner, D.R. The contribution of exogenous and endogenous mutagens to in vivo mutations. Mutation Research 428: 11-15, 1999.

Neoh, S-H., Brisco, M.J., Firgaira, F.A., Trainor, K.J., Turner, D.R. and Morley, A.A. Rapid detection of the factor V Leiden (1691G>A) and haemochromatosis (845G>A) mutation by fluorescence resonance energy transfer (FRET) and real-time PCR. J Clinical Pathology 52: 766-769, 1999.

Pinnock, C.B., Dadds, L., Marshall, V.R. and Roxby, D. Bladder mucosal cell abnormalities and symptomatic outcome after TURP. Urology 54: 834-838, 1999.

Roberts, G.W., Druskeit, T., Jorgensen, L.E., Wing, L.M.H., Gallus, A.S., Miller, C., Cosh, D. and Eaton, V.S. Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty?s protocol. Aust. N.Z. J. Med. 29: 731-736, 1999.

Sykes, P.J., Hooker, A.M. and Morley, A.A. Inversion due to intrachromosomal recombination produced by carcinogens in a transgenic mouse model. Mutation Research 427: 1-9, 1999.

Turner, D.R. Implications of the human genome project for movement disorders. In: "Movement Disorders ? New Developments", ed. R.A.C. Roos, Boerhaave Commissie voor Posacademish Onderwijs in de Geneeskunde (University of Leiden), pp 1-11 (1999) (ISBN 90-6767-429-X).

Warren, L.J., Simmer, K., Roxby, D., Grist, S., Seshadri, R. and Morley, A.A. DNA polymorphism in transfusion-associated graft-versus-host disease. J. Paediatrics and Child Health 35: 98-101, 1999.

back to top



Bierer, P., Holt, A.W., Berstein, A.D., Plummer, J.L. and A.H. Chalmers. Haemolysis associated with continuous venovenous renal replacement circuits. Anaesth. Intensive Care 26: 272-275, 1998.

Blake-Mortimer, J.S., Winefield, A.H. and Chalmers, A.H. Evidence for free radical-mediated reduction of lymphocytic 5'ectonucleotidase during stress. Int. J. Stress Management 5: 57-75, 1998.

Blake-Mortimer, J.S., Winefield, A.H. and Chalmers, A.H. The effect of depression in an animal model on 5?-ectonucleotidase, antibody production and tissue ascorbate stores. Journal of General Psychology 125: 129-146, 1998.

Brown, R.D., Luo, X-F., Gibson, J., Brisco, M., Sykes, P., Morley, A. and Joshua, D. Longitudinal analysis of circulating myeloma cells detected by allele specific mRNA in situ hybridization. Am. J. Haem. 58: 273-277, 1998.

Chalmers, A.H. and Kiley, M. Detection of xanthochromia in cerebrospinal fluid. Clin. Chem. 44: 1740-1742, 1998.

Gallus, A.S. Prevention of deep leg vein thrombosis. Aust. Prescriber 21: 37-39, 1998.

Gallus, A.S. Treatment of deep leg vein thrombosis. Aust. Prescriber 21: 64-66, 1998.

Gallus, A.S., Nurmohammed, M., Kearon, C. and Prins, M. Thromboprophylaxis in non-surgical patients: Who, when and how? Haemostasis 28 (Suppl. 3): 71-82, 1998.

Iacopetta, B., Powell, B., Grieu, F., Soong, R and Seshadri, R. Analysis of p53 gene mutation by rapid polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clinical Cancer Res. 4:1597-1602, 1998.

Mayers, M.M., Seshadri, R., Raymond, W., McCaul, K and Horsfall, D.J. Tumor microvascularity has no independent prognostic significance for breast cancer. Pathology 30:105-110, 1998.

McEvoy, C.R.E., Seshadri, R. and Firgaira, F.A. Large DNA fragment sizing using native acrylamide gels on an automated DNA sequencer and GENESCANTM software. BioTechniques 25: 464-470, 1998.

Morley, A.A. Quantifying leukemia. New Engl. J. Med. 339: 627-629, 1998.

Morley, A.A. Somatic mutation and aging. Annals NY Academy Sciences 854: 20-23, 1998.

Odagiri, Y., Uchida, H., Hosokawa, M., Takemoto, K., Morley, A.A. and Takeda, T. Accelerated accumulation of somatic mutations with age in lymphocytes of the senescence-accelerated mouse (SAM). Nature Genetics 19: 117-118, 1998.

Peng, L-M., Brisco, M.J. and Morley, A.A. A method for assessing strand breaks in DNA. Analytical Biochemistry 262: 9-16, 1998.

Sykes, P.J., Brisco, M.J., Hughes, E., Snell, L.E., Dolman, G., Neoh, S-H., Peng, L-M., Toogood, I., Venables, W.N. and Morley, A.A. Minimal residual disease in childhood acute lymphoblastic leukaemia quantified by aspirate and trephine: Is the disease multifocal? British Journal of Haematology 103: 60-65, 1998.

Sykes, P.J., Hooker, A.M., Harrington, C.S., Jacobs, A.K., Kingsbury, L. and Morley, A.A. Induction of somatic intrachromosomal recombination inversion events by cyclophosphamide in a transgenic mouse model. Mut. Res. 397: 209-219, 1998.

Van den Belt, A.G., Bossuyt, P.M., Prins, M.H., Gallus, A.S. and Buller H.R. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ? an economic evaluation. TASMAN Study Group. Thrombosis and Haemostasis 79: 259-263, 1998.

Warren, J.D., Firgaira, F.A., Thompson, E.M., Kneebone, C.S., Blumbergs, P.C. and Thompson, P.D. The causes of sporadic and "senile" chorea. Aust. N.Z.J. Med. 28: 429-431, 1998.

Whitmore, S., Crawford, J., Apostolou, S., Eyre, H., Baker, E., Lower, K., Settasatian, C., Goldup, S., Seshadri, R., Gibson, R.A., Mathew, C.G., Cleton-Jansen, A.M., Savoia, A., Pronk, J.C., Auerbach, A.D., Doggett, N., Sutherland, G and Callen, D.F. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: A region of frequent loss of heterozygosity in sporadic breast cancer. Genomics, 50, 1-8, 1998.

Whitmore, S., Settasatian, C., Crawford, J., Lower, K., McCallum, B., Seshadri, R., Cornelisse, C.J., Moerland, E.W., Cleton-Jansen, A.M., Tipping, A.J., Mathew, C.G., Savnio, M., Verlander, P., Auerbach, A.D., Van berkel, C., Pronk, J.C., Doggett, N.A., and Callen, D.F. Characterization ans screening for mutations of the growth arrest specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer. Genomics 52, 325-331, 1998.

back to top